BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:There aren’t many targets like BCMA - well validated\, prefere ntially expressed by mature B lymphocytes and specific to multiple myelom a – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients\, a large proportion of whom continue to experience poo r tolerability\, duration of response and develop resistance.\n\nAs such\ , the BCMA Targeted Therapies Summit returns for its second year\, as the industry’s definitive conference dedicated to:\n\n- Exploring and differ entiating the next-generation drug modalities targeting BCMA\, including bispecific antibody constructs\, antibody–drug conjugates\, and chimeric antigen receptor (CAR)-modified T-cell therapy\n\n- Rationalizing combina tion approaches and crack the sequencing conundrum to overcome resistance mechanisms\n\n- Sharing toxicology and safety data to optimize drug pote ncy and balancing dose-response relationships\, particularly when it come s to combination strategies\n\n- Investigating multiple myeloma biology a nd quantify BCMA using optimized preclinical models and assays to acceler ate translation of preclinical assets into the clinic\n\nFollowing the re cent FDA approval of Cilta-Cel from Janssen Pharmaceutical Companies of J ohnson &\; Johnson &\; Legend Biotech Corporation in Relapsed/Refra ctory Multiple Myeloma\, marking J&\;J’s first cell therapy approval\, the space is set to expect many more &\; there is truly nowhere bette r to unite with this exploding community and progress your drug developme nt than at this exclusive ‘gathering of minds’.\n DTEND:20220714T163000 DTSTAMP:20260512T232253Z DTSTART:20220712T090000 LOCATION:The Bostonian\, 26 North Street\, Boston\, Massachusetts\, 02109\, SEQUENCE:0 SUMMARY:There aren’t many targets like BCMA - well validated\, preferentia lly expressed by mature B lymphocytes and specific to multiple myeloma – meaning t... UID:76fdac45-a559-442e-ac7a-5228cf972392 END:VEVENT END:VCALENDAR